Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Nonin Medical is a 40-year-old, established leader in noninvasive pulse oximetry and patient monitoring devices. The company serves a diverse market including hospitals, EMS, OEMs, and home healthcare with a portfolio of FDA-cleared, medical-grade products. Recent strategic moves include launching a cloud-based data platform (Nonin Health®) and an over-the-counter fingertip oximeter (TruO2® OTC), expanding its reach into digital health and direct-to-consumer markets. As a private company, it leverages a strong OEM business and a reputation for rugged, reliable technology to maintain its competitive position.

RespiratoryCritical CareSleep MedicineCardiopulmonary

Technology Platform

Noninvasive optical sensing (pulse oximetry, regional oximetry) and a cloud-based remote patient monitoring data platform (Nonin Health®). Core expertise in durable sensor design, low-power electronics, and algorithms for accurate readings across skin tones and in low-perfusion/motion conditions.

Funding History

1
UndisclosedUndisclosed

Opportunities

Significant growth is driven by the expansion of home-based care and remote patient monitoring, creating demand for connected platforms like Nonin Health®.
Increased focus on health equity presents a competitive edge for their skin-tone-agnostic technology (TruO2 OTC), potentially capturing market share from less accurate devices.

Risk Factors

The company faces intense competition from large, well-capitalized medical device corporations and low-cost consumer electronics manufacturers.
Transitioning to a connected platform model introduces risks related to cybersecurity, software reliability, and changing reimbursement landscapes for remote monitoring services.

Competitive Landscape

Nonin competes in a crowded market dominated by giants like Masimo, Medtronic, and Philips, which have broader portfolios and greater sales reach. Its differentiation lies in its rugged device reputation, strong OEM business, and recent focus on equitable accuracy and a dedicated cloud platform, carving out niches in EMS, specific clinical settings, and the FDA-cleared OTC segment.